112 related articles for article (PubMed ID: 35441613)
1. Diagnostic value of serum sphingolipids in patients with colorectal cancer.
Pan Z; Hu Z; Guan L; Zhang L; Gao X; Yang L; Gong T; Hu Y; Zhao Y; Yu H
Analyst; 2022 May; 147(10):2189-2197. PubMed ID: 35441613
[No Abstract] [Full Text] [Related]
2. The identification of novel stroke-related sphingolipid biomarkers using UPLC-MS/MS.
Yang Z; Deng X; Zhu J; Chen S; Jiao C; Ruan Y
Clin Chim Acta; 2024 Jan; 552():117652. PubMed ID: 37979606
[TBL] [Abstract][Full Text] [Related]
3. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.
Shen S; Yang L; Li L; Bai Y; Cai C; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():41-48. PubMed ID: 29028617
[TBL] [Abstract][Full Text] [Related]
4. The potential serum sphingolipid biomarkers for distinguishing Wilson disease.
Tang S; Liang C; Yu H; Hou W; Hu Z; Chen X; Duan Z; Zheng S
Clin Chim Acta; 2024 Jan; 553():117740. PubMed ID: 38145643
[TBL] [Abstract][Full Text] [Related]
5. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
6. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
7. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer.
Martín-Blázquez A; Díaz C; González-Flores E; Franco-Rivas D; Jiménez-Luna C; Melguizo C; Prados J; Genilloud O; Vicente F; Caba O; Pérez Del Palacio J
Sci Rep; 2019 Dec; 9(1):20198. PubMed ID: 31882610
[TBL] [Abstract][Full Text] [Related]
8. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
9. LC-HRMS based approach to identify novel sphingolipid biomarkers in breast cancer patients.
Bhadwal P; Dahiya D; Shinde D; Vaiphei K; Math RGH; Randhawa V; Agnihotri N
Sci Rep; 2020 Mar; 10(1):4668. PubMed ID: 32170160
[TBL] [Abstract][Full Text] [Related]
10. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
12. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
13. A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.
Jones JJ; Wilcox BE; Benz RW; Babbar N; Boragine G; Burrell T; Christie EB; Croner LJ; Cun P; Dillon R; Kairs SN; Kao A; Preston R; Schreckengaust SR; Skor H; Smith WF; You J; Hillis WD; Agus DB; Blume JE
Clin Colorectal Cancer; 2016 Jun; 15(2):186-194.e13. PubMed ID: 27237338
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A
Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
16. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
[TBL] [Abstract][Full Text] [Related]
17. Serum Trefoil Factor 3 as a Protein Biomarker for the Diagnosis of Colorectal Cancer.
Li Q; Wang K; Su C; Fang J
Technol Cancer Res Treat; 2017 Aug; 16(4):440-445. PubMed ID: 27760866
[TBL] [Abstract][Full Text] [Related]
18. Serum Expression of
Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
[TBL] [Abstract][Full Text] [Related]
19. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
[TBL] [Abstract][Full Text] [Related]
20. STUDY OF LIPID BIOMARKERS OF PATIENTS WITH POLYPS AND COLORECTAL CÂNCER.
Serafim PVP; Figueiredo AG; Felipe AV; Turco EGL; Silva IDCGD; Forones NM
Arq Gastroenterol; 2019; 56(4):399-404. PubMed ID: 31800736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
